Navigation Links
Arthrosurface Hits a $100 Million Milestone
Date:4/23/2012

FRANKLIN, Mass., April 23, 2012 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that, in March, it surpassed $100 Million in cumulative net revenue. While this milestone is a significant financial achievement for the Company, its management believes that this milestone evidences the ever growing population of patients seeking alternatives to total joint replacement procedures. "Joint preservation, getting patients back to an active lifestyle and delaying conventional joint replacements has been our goal from the beginning," said Steve Ek, COO.

Arthrosurface contends it is the first and only company to develop a line of anatomic inlay implants for early joint disease and remains the leader in patient-matching metallic resurfacing. With more than 160 different implant sizes and shapes, the Arthrosurface joint platform could be considered the best first implant for early joint arthritis. Its resurfacing implants are thin, contoured, sized according to the defect and shaped to the patient's native joint surface. It is believed that there is no other orthopaedics company in the world with products that allow surgeons to intraoperatively and directly assess the joint status and choose a matching implant that, during the surgical procedure, serves the specific clinical need of the patient. With Arthrosurface's HemiCAP® resurfacing, the implant is matched to the patient. This implant-fitting concept is contrary to standard joint replacement where the patient is "fitted" to an implant through a series of large bone and soft tissue cuts.

Arthrosurface's President, Steve Tallarida, said, "We knew the idea of intervening sooner rather than later, when joint damage is limited, went against the conventional wisdom of traditional orthopaedics. In the world of total joints, treatment is typically delayed until significant joint destruction has occurred. We decided to take our cue from other disciplines, such as cardiology and dentistry, where stents and fillings are the first line choices for early intervention. Patients should have the option of considering an interim treatment in order to resume a normal lifestyle while hopefully delaying joint disease progression." 


'/>"/>
SOURCE Arthrosurface, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthrosurface Crosses the 30,000 Patient and 100 Publication Milestones
2. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
3. Arthrosurface Continues to Expand into Fast Growing Shoulder Market
4. Arthrosurface® Hits the 20,000 Implant Milestone
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. Delcath Systems, Inc. Secures $20 Million Credit Facility
7. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
8. One Million Healthcare Providers Now Use the CAQH Universal Provider Datasource
9. Nile Therapeutics, Inc. Completes $1.34 Million Registered Direct Offering
10. Comprehensive Care Corporation Doubles Its 2011 Revenues to Over $71 Million
11. Nile Therapeutics, Inc. to Raise $1.4 Million in Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, a ... active in the biopharmaceutical, nutraceutical, and aquacultural feed ... of its lead drug candidates, AGR131.  This drug ... cytokine from the blood of patients suffering from ... inflammatory bowel disease. ...
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics , ... Dallas, Texas , has received notice from the ... Institutes of Health (NIH) that it has been awarded ... totaling over $650,000 in 2017 with an additional $1,000,000 ... Investigational New Drug application of their lead non-opioid drug ...
Breaking Medicine Technology:
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... Greenfield Advisors ... companies in the U.S. for the second year in a row. The Inc. 5000 ... past three years. , “To be on the list once is a great accomplishment, ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second year, ... student to educate the public on the impact of concussions. Brooke Mills, student ... National Concussion Awareness Day. , Brooke is working diligently is to raise awareness ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... of their recently launched community enrichment program. Partnering once again with Boys & ... Superstar competition to help find the area’s very own American Idol. With all ...
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the ... from around the world, is excited to announce Andrew Ly as the winner of ... pursuits, covering textbook costs. , Ly, who is in his third year at ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable city ... (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities and ... Melbourne has consistently come in the top three of the index. So what is ...
Breaking Medicine News(10 mins):